BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24039404)

  • 61. Dissolving Microneedle Arrays with Optimized Needle Geometry for Transcutaneous Immunization.
    Li Y; Hu X; Dong Z; Chen Y; Zhao W; Wang Y; Zhang L; Chen M; Wu C; Wang Q
    Eur J Pharm Sci; 2020 Aug; 151():105361. PubMed ID: 32422374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Microneedle, bio-microneedle and bio-inspired microneedle: A review.
    Ma G; Wu C
    J Control Release; 2017 Apr; 251():11-23. PubMed ID: 28215667
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new computational method of modeling and evaluation of dissolving microneedle for drug delivery applications: Extension to theoretical modeling of a novel design of microneedle (array in array) for efficient drug delivery.
    Zoudani EL; Soltani M
    Eur J Pharm Sci; 2020 Jul; 150():105339. PubMed ID: 32315773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
    McNamee M; Wong S; Guy O; Sharma S
    Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
    Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
    Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery.
    Chen BZ; Yang Y; Wang BB; Ashfaq M; Guo XD
    Int J Pharm; 2019 Feb; 556():338-348. PubMed ID: 30553955
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bletilla striata polysaccharide microneedle for effective transdermal administration of model protein antigen.
    Zhou P; Zhao S; Huang C; Qu Y; Zhang C
    Int J Biol Macromol; 2022 Apr; 205():511-519. PubMed ID: 35217076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders.
    Priya S; Tomar Y; Desai VM; Singhvi G
    Expert Opin Drug Deliv; 2023 Jun; 20(6):721-738. PubMed ID: 36893450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intradermal and transdermal drug delivery using microneedles - Fabrication, performance evaluation and application to lymphatic delivery.
    Sabri AH; Kim Y; Marlow M; Scurr DJ; Segal J; Banga AK; Kagan L; Lee JB
    Adv Drug Deliv Rev; 2020 Jan; 153():195-215. PubMed ID: 31634516
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.
    Rejinold NS; Shin JH; Seok HY; Kim YC
    Expert Opin Drug Deliv; 2016; 13(1):109-31. PubMed ID: 26559052
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine.
    Nayak A; Das DB
    Biotechnol Lett; 2013 Sep; 35(9):1351-63. PubMed ID: 23690030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Finite element analysis of hollow out-of-plane HfO
    Zhang YH; A Campbell S; Karthikeyan S
    Biomed Microdevices; 2018 Feb; 20(1):19. PubMed ID: 29455257
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
    Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
    Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Microneedles for drug delivery: trends and progress.
    Cheung K; Das DB
    Drug Deliv; 2016 Sep; 23(7):2338-2354. PubMed ID: 25533874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
    Chen MC; Huang SF; Lai KY; Ling MH
    Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
    Ling MH; Chen MC
    Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.